General form for registration of securities under the Securities Act of 1933

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.25.2
NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Product Information [Line Items]        
Equity method investment $ 7,233,000   $ 7,233,000
Federally insured limits 2,980,899   5,422,404 1,948,794
Inventory write-off 25,000   126,703  
Inventory non- current assets $ 196,315   $ 196,315
Product warranty Period 90 days   90 days  
Advertising costs $ 0 $ 0 $ 0 $ 0
Warrants [Member]        
Product Information [Line Items]        
Antidilutive shares   44,644 0 44,644
Employee Stock Options [Member]        
Product Information [Line Items]        
Antidilutive shares 475,368 1,387,775 606,452 1,387,775
Series D Convertible Preferred Stock [Member]        
Product Information [Line Items]        
Antidilutive shares 333,000 639,667 433,000 433,000
Series E Convertible Preferred Stock [Member]        
Product Information [Line Items]        
Antidilutive shares 5,172,416 4,541,667 5,172,416 3,833,334
Series F Convertible Preferred Stock [Member]        
Product Information [Line Items]        
Antidilutive shares     0 0
Minimum [Member]        
Product Information [Line Items]        
Product warranty Period 12 months   12 months  
Maximum [Member]        
Product Information [Line Items]        
Product warranty Period 36 months   36 months  
Patents [Member]        
Product Information [Line Items]        
Estimated useful life of intangible assets 17 years   17 years  
Customer 1 [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage 60.00% 31.00% 34.00% 48.00%
Customer 1 [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage 89.00%   73.00% 83.00%
Customer 2 [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage   30.00% 31.00% 30.00%
Customer 2 [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage     17.00% 11.00%
Customer 3 [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage 18.00% 26.00% 13.00% 11.00%
Customer 3 [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage     10.00%  
Customer 4 [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]        
Product Information [Line Items]        
Concentration risk, percentage 11.00%   12.00%  
Three Customer [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | UNITED STATES        
Product Information [Line Items]        
Concentration risk, percentage 14.00% 61.00% 45.00% 44.00%
Sawgrass Parent [Member]        
Product Information [Line Items]        
Deferred revenue $ 7,200,000      
Equity method investment     $ 7,200,000  
Asset Management Agreement [Member]        
Product Information [Line Items]        
Carrying value of common units received 7,200,000   7,200,000  
Deferred revenue     $ 7,200,000  
Equity method investment $ 7,200,000